Association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility: An updated meta-analysis

International Journal of Genomics

Volumn 2014, Issue , 2014, Pages

  Yang, Xiao ^a   Li, Pengchao ^a   Tao, Jun ^a   Qin, Chao ^a   Cao, Qiang ^a   Gu, Jinbao ^a   Deng, Xiaheng ^a   Wang, Jun ^a   Liu, Xuzhong ^a   Wang, Zijie ^a   Wu, Bian ^a   Gu, Min ^a   Lu, Qiang ^a   Yin, Changjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ASIAN; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDEL MUTATION; META ANALYSIS; MOUTH CANCER; NFKB1 GENE; OVARY CANCER; PROMOTER REGION; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REVIEW;

EID: 84901801011     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2014/612972     Document Type: Review

References (45)

1. WHO, The GLob L Burden of Disease: 2004 Update 2008 Geneva, Switzerland World Health Organization
2. Foulkes W. D., Inherited susceptibility to common cancers. The New England Journal of Medicine 2008 359 20 2143 2153
3. Sen R., Baltimore D., Inducibility of K immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism. Cell 1986 47 6 921 928 2-s2.0-0022930702 (Pubitemid 17005065)
4. Chen F., Castranova V., Shi X., Demers L. M., New insights into the role of nuclear factor- B, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 1999 45 1 7 17 2-s2.0-0032900439 (Pubitemid 29036378)
5. Sun X. F., Zhang H., NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histology and histopathology 2007 22 12 1387 1398 2-s2.0-34548545268 (Pubitemid 47470331)
6. Chen F., Castranova V., Shi X., Demers L. M., New insights into the role of nuclear factor- B, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 1999 45 1 7 17 2-s2.0-0032900439 (Pubitemid 29036378)
7. Yu Y., Wan Y., Huang C., The biological functions of NF- B1 (p50) and its potential as an anti-cancer target. Current Cancer Drug Targets 2009 9 4 566 571 2-s2.0-67649364424 10.2174/156800909788486759
8. Karban A. S., Okazaki T., Panhuysen C. I. M., Gallegos T., Potter J. J., Bailey-Wilson J. E., Silverberg M. S., Duerr R. H., Cho J. H., Gregersen P. K., Wu Y., Achkar J. P., Dassopoulos T., Mezey E., Bayless T. M., Nouvet F. J., Brant S. R., Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human Molecular Genetics 2004 13 1 35 45 2-s2.0-0347917295 10.1093/hmg/ddh008 (Pubitemid 38072133)
9. Zou Y. F., Yuan F. L., Feng X. L., Tao J. H., Ding N., Pan F. M., Wang F., Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: A meta-analysis. Cancer Investigation 2011 29 1 78 85 2-s2.0-78650447464 10.3109/07357907.2010.535054
10. Cai H., Sun L., Cui L., Cao Q., Qin C., Zhang G., Mao X., Wang M., Zhang Z., Shao P., Yin C. A., Functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal Cell Carcinoma. Urologia Internationalis 2013 91 2 206 212
11. Lewander A., Butchi A. K. R., Gao J., He L. J., Lindblom A., Arbman G., Carstensen J., Zhang Z. Y., Sun X. F., Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scandinavian Journal of Gastroenterology 2007 42 11 1332 1338 2-s2.0-35148860766 10.1080/00365520701396026 (Pubitemid 47537062)
12. Li P., Gu J., Yang X., Cai H., Tao J., Yang X., Lu Q., Wang Z., Yin C., Gu M., Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a chinese population. PLoS ONE 2013 8 8 e71604
13. Cochran W. G., The comparison of percentages in matched samples. Biometrika 1950 37 3-4 256 266 2-s2.0-78651015947
14. Egger M., Smith G. D., Schneider M., Minder C., Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997 315 7109 629 634 2-s2.0-0030922816 (Pubitemid 27387172)
15. Stuck A. E., Rubenstein L. Z., Wieland D., Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. British Medical Journal 1998 316 7129 469 471 2-s2.0-0032491933 (Pubitemid 28121311)
16. Lin S. C., Liu C. J., Yeh W. I., Lui M. T., Chang K. W., Chang C. S., Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Letters 2006 243 1 47 54 2-s2.0-33749444114 10.1016/j.canlet.2005.11.019 (Pubitemid 44508646)
17. Riemann K., Becker L., Struwe H., Rübben H., Eisenhardt A., Siffert W., Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. International Journal of Clinical Pharmacology and Therapeutics 2007 45 8 423 430 2-s2.0-34547837548 (Pubitemid 47243938)
18. Bu H., Rosdahl I., Sun X. F., Zhang H., Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. Journal of Cancer Research and Clinical Oncology 2007 133 11 859 866 (Pubitemid 350218912)
19. Lo S. S., Chen J. H., Wu C. W., Lui W. Y., Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 2009 145 3 280 285 2-s2.0-60149110802 10.1016/j.surg.2008.11. 001
20. Zhang P., Wei Q., Li X., Wang K., Zeng H., Bu H., Li H., A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genetics and Cytogenetics 2009 191 2 73 77 2-s2.0-65549154260 10.1016/j.cancergencyto.2009.01.017
21. Burnik F. S., Yalçin S., NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy 2009 55 5 381 385 2-s2.0-70049083278 10.1159/000237744
22. Zhou B., Rao L., Li Y., Gao L., Wang Y., Chen Y., Xue H., Song Y., Peng Y., Liao M., Zhang L., A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Letters 2009 275 1 72 76 2-s2.0-58549113421 10.1016/j.canlet.2008.10.002
23. Tang T., Cui S., Deng X., Gong Z., Jiang G., Wang P., Liao B., Fei Z., Xian S., Zeng D., Li J., Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA and Cell Biology 2010 29 1 9 12 2-s2.0-74049163663 10.1089/dna.2009.0937
24. Andersen V., Christensen J., Overvad K., Tjønneland A., Vogel U., Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010 10, article 484 2-s2.0-77956483124 10.1186/1471-2407-10-484
25. Zhou B., Qie M., Wang Y., Yan L., Zhang Z., Liang A., Wang T., Wang X., Song Y., Zhang L., Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Annals of Oncology 2009 21 3 506 511 2-s2.0-77949593559 10.1093/annonc/mdp507 mdp507
26. Fan Y., Yu W., Ye P., Wang H., Wang Z., Meng Q., Duan Y., Liang X., An W., NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA and Cell Biology 2011 30 4 241 245 2-s2.0-79953243447 10.1089/dna.2010.1107
27. Lin C. W., Hsieh Y. S., Hsin C. H., Su C. W., Lin C. H., Wei L. H., Yang S. F., Chien M. H., Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS ONE 2012 7 4 2-s2.0-84859584568 10.1371/journal.pone.0035078 e35078
28. Vangsted A. J., Nielsen K. R., Klausen T. W., Haukaas E., Tjønneland A., Vogel U., A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma. British Journal of Haematology 2012 158 4 515 518 2-s2.0-84860217737 10.1111/j.1365-2141.2012. 09141.x
29. Huo Z. H., Zhong H. J., Zhu Y. S., Xing B., Tang H., Roles of functional NFKB1 and β -TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility. Genetics and Molecular Research 2013 12 3 3435 3443
30. Cheng C. W., Su J. L., Lin C. W., Su C. W., Shih C. H., Yang S. F., Chien M. H., Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS ONE 2013 8 2 e56130
31. Mohd Suzairi M. S., Tan S. C., Ahmad Aizat A. A., Mohd Aminudin M., Siti Nurfatimah M. S., Andee Z. D., Ankathil R., The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiology 2013 37 5 634 638
32. Kopp T. I., Friis S., Christensen J., Tjønneland A., Vogel U., Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genetics 2013 206 7-8 266 78
33. Karin M., Nuclear factor- B in cancer development and progression. Nature 2006 441 7092 431 436 2-s2.0-33745298519 10.1038/nature04870 (Pubitemid 44050137)
34. Li Q., Verma I. M., NF-kappaB regulation in the immune system. Nature Reviews Immunology 2002 2 10 725 734
35. Mukhopadhyay T., Roth J. A., Maxwell S. A., Altered expression of the p50 subunit of the NF- B transcription factor complex in non-small cell lung carcinoma. Oncogene 1995 11 5 999 1003 2-s2.0-0029114985
36. Bours V., Dejardin E., Goujon-Letawe F., Merville M. P., Castronovo V., The NF- B transcription factor and cancer: high expression of NF- B- and I B-related proteins in tumor cell lines. Biochemical Pharmacology 1994 47 1 145 149 2-s2.0-0028049074 10.1016/0006-2952(94)90448-0 (Pubitemid 24045827)
37. Karsan A., Yee E., Kaushansky K., Harlan J. M., Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996 87 8 3089 3096 2-s2.0-0029915833 (Pubitemid 26115335)
38. Kumar S., Baglioni C., Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor Type-2. Journal of Biological Chemistry 1991 266 31 20960 20964 2-s2.0-0025746246 (Pubitemid 21908558)
39. LaCasse E. C., Baird S., Korneluk R. G., MacKenzie A. E., The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998 17 25 3247 3259 2-s2.0-0032410818 (Pubitemid 29043977)
40. Glauert H. P., Tharappel J. C., Banerjee S., Chan N. L. S., Kania-Korwel I., Lehmler H. J., Lee E. Y., Robertson L. W., Spear B. T., Inhibition of the promotion of hepatocarcinogenesis by 2,2′4,4′5,5′- hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF- B in mice. Toxicology and Applied Pharmacology 2008 232 2 302 308 2-s2.0-52049093879 10.1016/j.taap.2008.06.013
41. Cahir-McFarland E. D., Davidson D. M., Schauer S. L., Duong J., Kieff E., NF- B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proceedings of the National Academy of Sciences of the United States of America 2000 97 11 6055 6060 2-s2.0-0034705110 (Pubitemid 30367522)
42. Bernal-Mizrachi L., Lovly C. M., Ratner L., The role of NF- B-1 and NF- B-2-mediated resistance to apoptosis in lymphomas. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9220 9225 2-s2.0-33745167654 10.1073/pnas.0507809103 (Pubitemid 43902559)
43. Yang L., Cohn L., Zhang D. H., Homer R., Ray A., Ray P., Essential role of nuclear factor B in the induction of eosinophilia in allergic airway inflammation. Journal of Experimental Medicine 1998 188 9 1739 1750 2-s2.0-0032476742 10.1084/jem.188.9.1739 (Pubitemid 28516118)
44. Artis D., Kane C. M., Fiore J., Zaph C., Shapira S., Joyce K., MacDonald A., Hunter C., Scott P., Pearce E. J., Dendritic cell-intrinsic expression of NF- B1 is required to promote optimal Th2 cell differentiation. Journal of Immunology 2005 174 11 7154 7159 2-s2.0-21044435329 (Pubitemid 40705682)
45. Shukla S., MacLennan G. T., Marengo S. R., Resnick M. I., Gupta S., Constitutive activation of PI3K-Akt and NF- B during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005 64 3 224 239 2-s2.0-22144449607 10.1002/pros.20217 (Pubitemid 40980864)